CaMKII: do not work too hard in the failing heart

Min Liu1, You Li, Ruichuan Chen

  • 1State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, 361101, China.

The Journal of Pathology
|January 8, 2015
PubMed

Insights

Calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) is elevated in heart disease, driving pathological hypertrophy and heart failure by activating fetal genes. This suggests current heart failure therapies may pose risks.

Area of Science:

  • Cardiovascular Biology
  • Molecular Pathology
  • Gene Regulation

Background:

  • Calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) is implicated in cardiac pathophysiology.
  • Distinguishing between pathological hypertrophy and heart failure remains a clinical challenge.

Purpose of the Study:

  • To investigate the role of CaMKIIδ in pathological cardiac hypertrophy and heart failure.
  • To elucidate the molecular mechanisms by which CaMKIIδ influences cardiac gene expression.

Main Methods:

  • Analysis of CaMKIIδ levels in human and mouse heart samples.
  • Investigation of CaMKIIδ-mediated histone modification and protein interactions.
  • Assessment of CaMKIIδ's role in regulating fetal gene transcription.

Main Results:

  • CaMKIIδ levels are increased in both pathological cardiac hypertrophy and heart failure.
  • CaMKIIδ phosphorylates histone H3 at serine 10 (H3S10).
  • H3S10 phosphorylation recruits 14-3-3 proteins, activating fetal gene transcription.

Conclusions:

  • CaMKIIδ is a key mediator linking pathological hypertrophy to heart failure.
  • The findings suggest a continuum between these cardiac conditions.
  • Current heart failure treatments may carry risks due to CaMKIIδ involvement.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
807
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
631
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
806
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K